Abirapro Abiraterone 250mg Tablets

Abirapro Abiraterone 250mg Tablets

14282 INR

Product Details:

  • Drug Type External Use Drugs
  • Physical Form Tablets
  • Function Cancer Treatment
  • Dosage 250mg
  • Suitable For Teenagers Women Adults Aged Person
  • Storage Instructions Dry Palace
  • Click to View more
X

Abirapro Abiraterone 250mg Tablets Price And Quantity

  • 10 Box
  • 14282 INR

Abirapro Abiraterone 250mg Tablets Product Specifications

  • Dry Palace
  • Teenagers Women Adults Aged Person
  • Tablets
  • 250mg
  • Cancer Treatment
  • External Use Drugs

Abirapro Abiraterone 250mg Tablets Trade Information

  • Letter of Credit at Sight (Sight L/C) Western Union Telegraphic Transfer (T/T) Cash in Advance (CID) Cheque Cash Advance (CA)
  • 100 Box Per Day
  • 1 Week
  • Western Europe Australia North America South America Eastern Europe Middle East Central America Africa Asia
  • All India

Product Description

WHAT IS THE IMPORTANT SAFETY INFORMATION OF ABIRAPRO 250 MG TABLETS ?

  • You should not use Abirapro if you have severe liver disease.

  • Although Abiraterone is not for use by women, this medicine can harm an unborn baby or cause birth defects. The tablets should not be handled by a woman who is pregnant or who may become pregnant.

  • It is not known whether Abiraterone passes into breast milk or if it could harm a nursing baby. Abiraterone should not be used by a woman who is breast-feeding a baby.

  • WHAT IS ABIRAPRO 250MG TABLETS ?

    Abiraterone works by reducing androgen production in the body. Androgens are male hormones that can promote tumor growth in the prostate gland.

    WHAT IS THE USE OF ABIRAPRO 250MG TABLETS ?

    Abirapro is used together with prednisone to treat prostate cancer that has spread to other parts of the body.

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Anticancer Drugs' category



We mainly export our products to the foreign countries.
&
We are accepting bulk order quantity.
Back to top
trade india member
3S CORPORATION All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.